NN Investment Partners Holdings N.V. Buys 868 Shares of Danaher Co. (DHR)

NN Investment Partners Holdings N.V. increased its stake in shares of Danaher Co. (NYSE:DHR) by 13.0% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 7,545 shares of the conglomerate’s stock after purchasing an additional 868 shares during the period. NN Investment Partners Holdings N.V.’s holdings in Danaher were worth $820,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. FMR LLC raised its holdings in shares of Danaher by 10.3% in the 2nd quarter. FMR LLC now owns 21,011,026 shares of the conglomerate’s stock valued at $2,073,369,000 after acquiring an additional 1,963,116 shares in the last quarter. Putnam Investments LLC raised its holdings in shares of Danaher by 0.8% in the 2nd quarter. Putnam Investments LLC now owns 6,385,003 shares of the conglomerate’s stock valued at $630,072,000 after acquiring an additional 51,596 shares in the last quarter. Findlay Park Partners LLP raised its holdings in shares of Danaher by 4.8% in the 2nd quarter. Findlay Park Partners LLP now owns 3,825,000 shares of the conglomerate’s stock valued at $377,451,000 after acquiring an additional 175,000 shares in the last quarter. Schroder Investment Management Group raised its holdings in shares of Danaher by 0.3% in the 2nd quarter. Schroder Investment Management Group now owns 2,765,853 shares of the conglomerate’s stock valued at $272,768,000 after acquiring an additional 9,606 shares in the last quarter. Finally, Fred Alger Management Inc. raised its holdings in shares of Danaher by 7.1% in the 2nd quarter. Fred Alger Management Inc. now owns 2,749,640 shares of the conglomerate’s stock valued at $271,334,000 after acquiring an additional 181,154 shares in the last quarter. 76.80% of the stock is currently owned by institutional investors and hedge funds.

DHR has been the topic of several recent analyst reports. ValuEngine raised Danaher from a “hold” rating to a “buy” rating in a report on Thursday, July 12th. Zacks Investment Research raised Danaher from a “hold” rating to a “buy” rating and set a $119.00 price target on the stock in a report on Wednesday, September 19th. Morgan Stanley increased their price objective on Danaher from $120.00 to $122.00 and gave the company an “overweight” rating in a research report on Friday, July 20th. Royal Bank of Canada increased their price objective on Danaher to $107.00 and gave the company a “positive” rating in a research report on Thursday, July 19th. They noted that the move was a valuation call. Finally, Robert W. Baird reduced their price objective on Danaher from $116.00 to $114.00 and set an “outperform” rating on the stock in a research report on Friday, October 19th. One investment analyst has rated the stock with a hold rating and fifteen have given a buy rating to the company. The company has an average rating of “Buy” and an average price target of $112.14.

In other news, EVP William K. Daniel sold 103,086 shares of Danaher stock in a transaction that occurred on Friday, August 10th. The stock was sold at an average price of $100.63, for a total value of $10,373,544.18. Following the sale, the executive vice president now directly owns 167,080 shares in the company, valued at approximately $16,813,260.40. The sale was disclosed in a filing with the SEC, which is available through this link. Also, insider William King sold 53,433 shares of Danaher stock in a transaction that occurred on Monday, November 5th. The stock was sold at an average price of $101.64, for a total value of $5,430,930.12. Following the completion of the sale, the insider now owns 36,425 shares in the company, valued at $3,702,237. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 196,881 shares of company stock worth $19,737,553. 11.90% of the stock is owned by corporate insiders.

Shares of Danaher stock opened at $104.07 on Thursday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.08 and a current ratio of 1.53. The stock has a market cap of $70.95 billion, a PE ratio of 25.82, a PEG ratio of 1.95 and a beta of 1.04. Danaher Co. has a 12 month low of $91.65 and a 12 month high of $110.13.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Thursday, October 18th. The conglomerate reported $1.10 EPS for the quarter, beating the consensus estimate of $1.07 by $0.03. The firm had revenue of $4.85 billion for the quarter, compared to analyst estimates of $4.80 billion. Danaher had a return on equity of 11.59% and a net margin of 14.07%. The company’s revenue was up 7.2% on a year-over-year basis. During the same period in the prior year, the company earned $1.00 EPS. Research analysts forecast that Danaher Co. will post 4.51 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Friday, October 26th. Investors of record on Friday, September 28th were given a dividend of $0.16 per share. The ex-dividend date of this dividend was Thursday, September 27th. This represents a $0.64 annualized dividend and a yield of 0.61%. Danaher’s payout ratio is 15.88%.

TRADEMARK VIOLATION WARNING: This piece of content was originally reported by WKRB News and is the property of of WKRB News. If you are reading this piece of content on another website, it was copied illegally and republished in violation of United States and international copyright & trademark law. The original version of this piece of content can be read at https://www.wkrb13.com/2018/11/08/nn-investment-partners-holdings-n-v-buys-868-shares-of-danaher-co-dhr.html.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

Featured Story: Earnings Per Share (EPS) Explained

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply